About 56% told Business Group on Health that the GLP-1 agonist obesity drugs are a major driver.

Some states that look similar may produce much different streams of commissions and fees.

The list of supporters has included an employer group, the Purchaser Business Group on Health.

She promised to work with businesses and fight to protect the current Affordable Care Act premium subsidy levels.

New to-do lists show the long-away final regulations could show up any day.

The fund is also using its $3.22-per-life fee to back studies on care effectiveness for other conditions, such as kidney stones and anxiety.

The ruling seems like ancient history, but efforts to adapt to it are just beginning.

Regulators are considering requiring hospitals to use ID numbers to help determine whether big facility fees reflect the care provided.